GeneDx Holdings Corp.

NASDAQ:WGS

Medical - Healthcare Information Services

Healthcare
$51.96 +2.69%

+$1.52 today

Market cap
$1.56B
Beta
1.97
P/E (TTM)
-21.8
EPS (TTM)
-$2.65
52W Low $32.21High $170.87

Volume 1.71M

Average 1.28M

WGS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

GeneDx Holdings Corp.NASDAQ: WGS

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 29.71M shares rose 4.0% year over year, in line with the +3.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +38.0% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +4.0% holds above the trailing-twelve-month pace of +3.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
29.71M+1.3% QoQ
Last fiscal yearDec 2025
26.89M+0.0% YoY
LTMJun 2026
28.68M+3.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.0%——
1 year+0.0%——
3-year CAGR+38.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
26.89M USD
Year-over-year change
+0.0%
4-year CAGR
+69.3%

Weighted Avg Shares vs competitors

How WGS compares with its peers on the latest reported figures

  • WGS's LTM Jun 2026 weighted avg shares of 28.68M shares is the 8th highest of the 9 companies compared; the peer median is 47.87M shares.
  • Its year-over-year change of +3.5% is the 3rd highest of 9, against a peer median of +2.3%.
  • Over three fiscal years its annual growth of +38.0% compares with a peer median of +5.0%.
WGS Competitors Peer median
Weighted Avg Shares for WGS and competitors
Company Period LTM YoY 3-year CAGR
NEONeoGenomics, Inc.LTM Jun 2026128.84M +1.3%+1.0%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
MDXHMDxHealth S.A.FY202550.03M +2.8%+46.6%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
IMDXInsight Molecular Diagnostics Inc.LTM Mar 202632.26M +85.3%+76.5%
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +3.5%+38.0%
CSTLCastle Biosciences, Inc.LTM Mar 202628.3M +0.9%+3.6%
Peer median (excluding WGS) 47.87M+2.3%+5.0%

Competitors are the stored peer set for WGS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue212.2M234.69M202.57M305.45M427.54M
Cost of Revenue228.8M261.44M112.56M111.05M129.37M
Gross Profit(16.6M)(26.75M)90.01M194.4M298.17M
Gross Margin-7.8%-11.4%44.4%63.6%69.7%
Research & Development105.16M86.2M58.27M45.72M72.03M
Selling, General & Admin318.73M338.24M194.71M168.48M239.22M
Operating Expenses429.55M640.9M270.6M217.61M311.25M
Depreciation & Amortization21.81M59.31M33.73M21.95M25.22M
EBITDA(220.75M)(398.2M)(136.46M)(27.64M)6.63M
EBITDA Margin-104.0%-169.7%-67.4%-9.1%1.5%
Operating Income(446.15M)(667.65M)(180.6M)(23.21M)(11.8M)
Operating Margin-210.3%-284.5%-89.2%-7.6%-2.8%
Interest Income79K2.54M1.11M00
Interest Expense2.84M3.21M03.03M2.54M
Other Income / Expenses200.76M69.62M3.9M(29.42M)(9.34M)
Income Before Tax(245.39M)(598.03M)(176.69M)(52.63M)(21.14M)
Pre-Tax Margin-115.6%-254.8%-87.2%-17.2%-4.9%
Income Tax Expense0(49.05M)(926K)(343K)(116K)
Net Income(245.39M)(548.98M)(175.77M)(52.29M)(21.02M)
Net Margin-115.6%-233.9%-86.8%-17.1%-4.9%
EPS (Basic)(74.93)(53.63)(7.23)(1.94)(0.73)
EPS (Diluted)(74.93)(53.63)(7.23)(1.94)(0.73)
Weighted Avg Shares3.28M10.24M24.31M26.89M26.89M
Weighted Avg Shares (Diluted)3.28M10.24M24.31M26.89M26.89M

GeneDx Holdings Corp.

NASDAQ:WGS

Intrinsic Alpha fair value

Locked

Current Price

$51.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.